(Q77111592)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10168752%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

title

The role of economic evaluation in the pricing and reimbursement of medicines (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10168752%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

author name string

M Drummond

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10168752%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

B Jönsson

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10168752%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

F Rutten

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10168752%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

publication date

1 June 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10168752%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10168752%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

volume

40

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10168752%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10168752%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

page(s)

199-215

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10168752%20AND%20SRC:MED&resulttype=core&format=json

Economic evaluation of pharmaceuticals: a European perspective

2 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2897%2900901-9

7 January 2021

New developments in pricing and drug reimbursement in France

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2897%2900901-9

7 January 2021

Pricing and reimbursement of pharmaceuticals in Sweden

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2897%2900901-9

7 January 2021

No cure, no pay: an acceptable way of financing fertility treatments?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2897%2900901-9

7 January 2021

A randomized, double-blind comparison of sumatriptan and Cafergot in the acute treatment of migraine. The Multinational Oral Sumatriptan and Cafergot Comparative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2897%2900901-9

7 January 2021

The emerging government requirement for economic evaluation of pharmaceuticals

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2897%2900901-9

7 January 2021

The Australian Guidelines for subsidisation of pharmaceuticals: the road to cost-effective drug prescribing?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2897%2900901-9

7 January 2021

Price regulation, industry structure and innovation: an international comparison of pharmaceutical industries.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2897%2900901-9

7 January 2021

Price regulation in the pharmaceutical industry: prescription or placebo?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2897%2900901-9

7 January 2021

10.1016/S0168-8510(97)00901-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10168752%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

1 reference